NM_000393.5:c.799-426A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000393.5(COL5A2):​c.799-426A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.873 in 152,200 control chromosomes in the GnomAD database, including 58,741 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.87 ( 58741 hom., cov: 33)

Consequence

COL5A2
NM_000393.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.691

Publications

4 publications found
Variant links:
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]
COL5A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, classic type, 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.948 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A2NM_000393.5 linkc.799-426A>G intron_variant Intron 11 of 53 ENST00000374866.9 NP_000384.2 P05997
COL5A2XM_011510573.4 linkc.661-426A>G intron_variant Intron 14 of 56 XP_011508875.1
COL5A2XM_047443251.1 linkc.661-426A>G intron_variant Intron 16 of 58 XP_047299207.1
COL5A2XM_047443252.1 linkc.661-426A>G intron_variant Intron 15 of 57 XP_047299208.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A2ENST00000374866.9 linkc.799-426A>G intron_variant Intron 11 of 53 1 NM_000393.5 ENSP00000364000.3 P05997
COL5A2ENST00000618828.1 linkc.169-426A>G intron_variant Intron 11 of 46 5 ENSP00000482184.1 A0A087WYX9

Frequencies

GnomAD3 genomes
AF:
0.873
AC:
132838
AN:
152084
Hom.:
58720
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.738
Gnomad AMI
AF:
0.968
Gnomad AMR
AF:
0.824
Gnomad ASJ
AF:
0.950
Gnomad EAS
AF:
0.816
Gnomad SAS
AF:
0.848
Gnomad FIN
AF:
0.959
Gnomad MID
AF:
0.889
Gnomad NFE
AF:
0.954
Gnomad OTH
AF:
0.876
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.873
AC:
132908
AN:
152200
Hom.:
58741
Cov.:
33
AF XY:
0.873
AC XY:
64956
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.738
AC:
30647
AN:
41516
American (AMR)
AF:
0.824
AC:
12598
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.950
AC:
3299
AN:
3472
East Asian (EAS)
AF:
0.815
AC:
4216
AN:
5172
South Asian (SAS)
AF:
0.848
AC:
4094
AN:
4826
European-Finnish (FIN)
AF:
0.959
AC:
10180
AN:
10610
Middle Eastern (MID)
AF:
0.884
AC:
260
AN:
294
European-Non Finnish (NFE)
AF:
0.954
AC:
64889
AN:
68004
Other (OTH)
AF:
0.875
AC:
1842
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
798
1596
2394
3192
3990
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
896
1792
2688
3584
4480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.879
Hom.:
20223
Bravo
AF:
0.855
Asia WGS
AF:
0.786
AC:
2729
AN:
3468

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
3.0
DANN
Benign
0.71
PhyloP100
-0.69
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6434322; hg19: chr2-189949189; API